Scientists and U.S. and European drug regulators have been searching for an explanation behind the rare but potentially deadly clots accompanied by low blood platelet counts.

Health Canada on Friday said that they were holding back 300,000 doses of the one-shot J&J vaccine — mere days before they were meant to be deployed.